Recombinant Mouse G-protein coupled receptor 143 (Gpr143)

What is GPR143 and why is it significant in research?

GPR143 is an atypical G protein-coupled receptor encoded by the ocular albinism 1 (OA1) gene. Unlike most GPCRs that localize to the plasma membrane, GPR143 is predominantly found intracellularly in endolysosomes and melanosomes. This receptor is significant because it plays critical roles in melanosome biogenesis and organization, and mutations in GPR143 cause X-linked Ocular Albinism Type 1 (OA1), resulting in hypopigmentation of the eyes and visual system abnormalities . From a research perspective, GPR143 represents one of the relatively rare intracellular GPCRs, offering insights into non-canonical GPCR signaling pathways and organelle regulation mechanisms .

What are the structural characteristics of GPR143 that make it unique among GPCRs?

GPR143 has not been assigned to any specific GPCR family due to its lack of common structural motifs found in canonical GPCRs. When examining the protein sequence against established GPCR motifs using the Ballesteros and Weinstein nomenclature:

These structural differences likely contribute to GPR143's atypical localization and function, making it an interesting subject for structure-function relationship studies in GPCR research .

What expression systems are optimal for producing recombinant mouse GPR143?

The choice of expression system significantly impacts protein yield, post-translational modifications, and functionality of recombinant mouse GPR143. Based on available research data, the following systems have been successfully employed:

For functional studies examining GPR143's intracellular signaling, the HEK-293 expression system is often preferred as it provides proper mammalian post-translational modifications essential for receptor activity .

How can researchers create a plasma membrane-localized version of GPR143 for ligand screening?

To overcome the challenge of GPR143's intracellular localization in ligand screening assays, researchers can generate a plasma membrane-targeted mutant by:

• Introducing specific mutations in the receptor's sorting signals: L223A-L224A (dileucine motif in ICL3) and W329A-E330A (tryptophan-glutamic acid doublet in C-terminal tail) .

• Validating plasma membrane localization through immunofluorescence microscopy using epitope tags.

• Confirming that the mutant retains functional activity comparable to wild-type GPR143 despite altered localization.

This approach has been successfully employed in β-arrestin recruitment assays, where researchers have demonstrated that the plasma membrane-localized mutant (pm-GPR143) maintains signaling capabilities similar to the wild-type receptor while providing better accessibility to potential ligands in the culture medium . This methodology enables high-throughput screening of compound libraries to identify modulators that would otherwise have limited access to the intracellularly-localized wild-type receptor .

What assays are most effective for measuring GPR143 activity in experimental settings?

Several complementary approaches can be employed to assess GPR143 activity:

• β-arrestin recruitment assays: These have been successfully implemented for high-throughput screening of GPR143 modulators. The methodology involves:

  • Transfection of CHO β-arrestin cells with wild-type or plasma membrane-localized GPR143

  • Exposure to test compounds (typically at 10 μM with 1% DMSO final concentration)

  • Detection of β-arrestin recruitment via chemiluminescence after 90-minute incubation

• Melanosome size and pigmentation assays: As GPR143 regulates melanosome biogenesis:

  • Treatment of melanocytes with potential GPR143 modulators

  • Quantification of changes in melanin content via spectrophotometry

  • Analysis of melanosome morphology and size via electron microscopy

• G-protein activation assays: To assess downstream signaling:

  • [35S]GTPγS binding assays to measure G-protein activation

  • Calcium mobilization assays

  • Measurement of cAMP levels to detect coupling to different G-protein subtypes

The choice of assay depends on the specific research question, with β-arrestin recruitment providing a robust screening platform, while melanocyte-based assays offer more physiologically relevant insights into GPR143 function .

How can researchers investigate GPR143's role in intracellular trafficking pathways?

To elucidate GPR143's function in intracellular trafficking:

• ESCRT machinery manipulation: Since GPR143 sorting and ubiquitination depend on endosomal sorting complexes required for transport (ESCRT):

  • Deploy siRNA-mediated depletion of ESCRT-0, -I, and -III subunits

  • Evaluate effects on GPR143 degradation and retention in the endosomal system

  • Assess changes in receptor ubiquitination patterns

• Live-cell imaging of protein trafficking:

  • Generate fluorescently-tagged GPR143 constructs

  • Implement pulse-chase experiments with lysosomal and melanosomal markers

  • Analyze co-localization dynamics over time using confocal microscopy

• Proximity labeling approaches:

  • Employ BioID or APEX2 fusion constructs with GPR143

  • Identify proximal proteins within the trafficking machinery

  • Validate interactions through co-immunoprecipitation and functional assays

Such approaches can reveal how GPR143 navigates between degradation pathways and melanosomal delivery, providing insights into the regulatory mechanisms controlling its intracellular distribution and function .

What strategies can be employed to identify endogenous ligands of GPR143?

Despite being classified as an orphan GPCR, several methodologies can be applied to identify potential endogenous ligands for GPR143:

• Untargeted metabolomics of melanosomes:

  • Isolate melanosomes from pigmented cells

  • Perform liquid chromatography-mass spectrometry analysis

  • Identify small molecules enriched in melanosomes that may interact with GPR143

• Displacement binding assays:

  • Utilize identified synthetic ligands as radioactive or fluorescent probes

  • Screen cellular extracts for molecules that compete for binding

  • Fractionate active extracts to isolate specific components

• Activity-guided fractionation:

  • Prepare extracts from tissues with high GPR143 expression

  • Test fractions in β-arrestin recruitment assays with pm-GPR143

  • Progressively purify active fractions to isolate candidate ligands

• Computational ligand prediction:

  • Generate homology models of GPR143's binding pocket

  • Perform in silico screening of endogenous metabolite libraries

  • Validate top candidates through functional assays

These complementary approaches may help deorphanize GPR143, potentially uncovering new signaling pathways relevant to pigmentation disorders and other associated pathologies .

How does GPR143 interact with other melanogenesis-associated proteins?

GPR143 has been described as a promiscuous receptor that interacts with multiple melanosomal proteins and other GPCRs, suggesting complex regulatory networks. To investigate these interactions:

• Protein-protein interaction screens:

  • Implement membrane yeast two-hybrid systems

  • Perform co-immunoprecipitation followed by mass spectrometry

  • Use proximity labeling techniques (BioID, APEX2) to identify the GPR143 interactome in melanocytes

• Functional genomics approaches:

  • Conduct CRISPR screens to identify genetic modifiers of GPR143 activity

  • Analyze epistatic relationships through combinatorial knockdown/overexpression studies

  • Assess melanosome morphology and pigmentation as phenotypic readouts

• Receptor heteromerization studies:

  • Employ bioluminescence/fluorescence resonance energy transfer (BRET/FRET)

  • Investigate potential interactions with other GPCRs involved in pigmentation

  • Determine how heteromerization affects signaling outcomes

Understanding these protein networks is critical for elucidating GPR143's broader physiological roles beyond melanogenesis, including potential functions in cancer progression, blood pressure regulation, and neuronal signaling .

How can researchers address the challenge of GPR143's constitutive activity in experimental settings?

GPR143 exhibits constitutive activity that can complicate the interpretation of experimental results, particularly in ligand identification studies. To address this challenge:

• Establish robust baseline measurements:

  • Include multiple negative controls in each experiment

  • Normalize all measurements to unstimulated receptor activity

  • Consider using inducible expression systems to control receptor levels

• Employ inverse agonists as tools:

  • The three compounds identified in previous studies that decrease constitutive GPR143 activity can serve as experimental controls

  • Use these compounds to establish a "fully inhibited" state of the receptor

  • Calculate compound efficacy relative to these reference modulators

• Implement appropriate statistical analyses:

  • Account for day-to-day variability in constitutive activity levels

  • Use area under the curve measurements for time-course experiments

  • Apply multiparametric analysis to distinguish true modulators from assay artifacts

These approaches can improve signal-to-noise ratios and facilitate the identification of subtle but physiologically relevant changes in GPR143 activity .

What are the potential pitfalls when comparing wild-type and plasma membrane-localized GPR143 mutants?

When utilizing plasma membrane-localized GPR143 mutants (pm-GPR143) as research tools, several important considerations should be addressed:

• Differences in microenvironment:

  • Wild-type GPR143 functions in an acidic melanosomal/lysosomal environment

  • pm-GPR143 experiences neutral extracellular pH and different lipid composition

  • These differences may affect ligand binding properties and signaling outcomes

• Altered protein interactions:

  • pm-GPR143 may lose access to intracellular interaction partners

  • Novel plasma membrane-associated proteins may create artifactual interactions

  • Perform comparative interactome analyses to identify location-dependent interactions

• Data interpretation challenges:

  • Compounds active against pm-GPR143 may not reach wild-type receptors due to cell permeability issues

  • Signaling kinetics may differ between the two receptor populations

  • Always validate findings from pm-GPR143 assays with wild-type receptor when possible

What emerging technologies could advance our understanding of GPR143 function?

Several cutting-edge technologies hold promise for unraveling the complex biology of GPR143:

• Cryo-electron microscopy:

  • Determination of GPR143's three-dimensional structure

  • Visualization of conformational changes upon activation

  • Identification of binding sites for potential ligands and interaction partners

• Organoid and induced pluripotent stem cell (iPSC) models:

  • Development of patient-derived pigmented organoids with GPR143 mutations

  • Investigation of GPR143 function in physiologically relevant cellular contexts

  • High-throughput phenotypic screening in disease-relevant models

• Advanced gene editing approaches:

  • Implementation of base editing to introduce specific point mutations

  • Development of conditional knockout models to study tissue-specific functions

  • Creation of knock-in reporter systems to monitor GPR143 activity in vivo

• Novel imaging technologies:

  • Super-resolution microscopy to visualize GPR143 trafficking in real-time

  • Correlation of structural and functional imaging to link receptor localization with activity

  • Multiplexed imaging to simultaneously track multiple components of GPR143-associated pathways

These technologies could provide unprecedented insights into GPR143 biology, potentially uncovering novel therapeutic approaches for pigmentation disorders and other conditions linked to GPR143 dysfunction .

How might research on GPR143 contribute to understanding broader disease mechanisms beyond pigmentation disorders?

Emerging evidence suggests that GPR143 may play roles in several pathophysiological processes beyond melanogenesis:

• Cancer progression and metastasis:

  • GPR143 has been proposed as a metastasis-promoting gene in melanoma progression

  • Researchers can investigate how GPR143 expression correlates with cancer outcomes

  • Studies may explore whether GPR143 modulators could serve as adjuvant therapies

• Cardiovascular regulation:

  • GPR143 has been implicated in blood pressure regulation

  • Future research could examine GPR143 expression in cardiovascular tissues

  • Animal models with tissue-specific GPR143 modifications could reveal novel functions

• Neurodevelopmental processes:

  • Given GPR143's role in the visual system development, investigations into broader neurodevelopmental functions are warranted

  • Studies might explore GPR143 expression patterns in different brain regions

  • Potential connections to other neurodevelopmental disorders could be evaluated

• Age-related macular degeneration:

  • GPR143's function in the retinal pigment epithelium suggests possible links to macular degeneration

  • Research could focus on how GPR143 activity changes during aging

  • Therapeutic targeting of GPR143 might offer new approaches for retinal disorders

Understanding these broader roles could position GPR143 as a multifunctional signaling hub with relevance to diverse physiological systems and pathological conditions .